Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Testing effectiveness (Phase 2)UnknownNCT04819971
What this trial is testing

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

Who this might be right for
Stomach Cancer
The First Affiliated Hospital of Zhengzhou University 67
Testing effectiveness (Phase 2)WithdrawnNCT03704077
What this trial is testing

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerCancer of the StomachStomach Cancer+1 more
Bristol-Myers Squibb
Testing effectiveness (Phase 2)UnknownNCT04278222
What this trial is testing

Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)

Who this might be right for
Gastric CancerImmunotherapyAnlotinib+1 more
Shanghai Changzheng Hospital 24
Testing effectiveness (Phase 2)UnknownNCT05198856
What this trial is testing

Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

Who this might be right for
Gastric Cancer Metastatic to Liver
Qilu Hospital of Shandong University 106
Not applicableLooking for participantsNCT04890171
What this trial is testing

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

Who this might be right for
Stomach CancerUndifferentiated TypeExpanded Indication of Endoscopic Resection
National Cancer Center, Korea 708
Testing effectiveness (Phase 2)Looking for participantsNCT07689851
What this trial is testing

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Large-scale testing (Phase 3)Looking for participantsNCT07518147
What this trial is testing

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 438
Not applicableNot Yet RecruitingNCT07352462
What this trial is testing

Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath

Who this might be right for
Respiratory InfectionsCOVID-19Influenza Virus Infection+1 more
Hospices Civils de Lyon 777
Not applicableUnknownNCT02716961
What this trial is testing

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerGemcitabine and Cisplatin ChemotherapyEpirubicin Instillation+2 more
The First Affiliated Hospital with Nanjing Medical University 208
Not applicableEnded earlyNCT01167777
What this trial is testing

Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

Who this might be right for
ChlamydiaGonorrhea
Siemens Healthcare Diagnostics Inc 2,296
Not applicableStudy completedNCT07180966
What this trial is testing

Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment Evaluation

Who this might be right for
Gastric Cancer (GC)
Ruijin Hospital 780
Not applicableLooking for participantsNCT07243015
What this trial is testing

Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers

Who this might be right for
Gastric Cancer
City of Hope Medical Center 500
Not applicableStudy completedNCT07147010
What this trial is testing

Evaluation of Correlations Between Volatile Organic Compounds and Venous Blood Glucose in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
DCB Research AG 20
Testing effectiveness (Phase 2)UnknownNCT05991518
What this trial is testing

IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

Who this might be right for
HER2 Gene Mutation
SUNHO（China）BioPharmaceutical CO., Ltd. 136
Not applicableUnknownNCT05802433
What this trial is testing

The Genetic Effects on Vitamin D Supplementation

Who this might be right for
Vitamin D Deficiency
St. Mary's University, Twickenham 67
Testing effectiveness (Phase 2)Looking for participantsNCT06808971
What this trial is testing

Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 61
Not applicableNot Yet RecruitingNCT07581730
What this trial is testing

A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases

Who this might be right for
Liver NeoplasmsGastric Cancer (GC)Gastric Cancer Metastatic to Liver
The First Hospital of Jilin University 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07609667
What this trial is testing

SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 80
Next Page